Research Article
Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study
Table 1
Demographic and clinical characteristics of the study patients.
| Variable | |
| Mean age at diagnosis, (±standard deviation) | 52.5 (±12.5) | Sex, number of patients (%) | | Male | 12 (31.6) | Female | 26 (68.4) | Race, number of patients (%) | | White | 32 (84.2) | Black | 3 (7.9) | Hispanic | 3 (7.9) | Median baseline body mass index, kg/m2 (range)* | 34.6 (20.3 to 54) | ACC stage, number of patients (%) | | I | 2 (5.3) | II | 18 (47.4) | III | 13 (34.2) | IV | 5 (13.2) | Functional status of ACC, number of patients (%) Functional | 15 (39.5) | Hypercortisolism, number of patients (%) | 7 (18.4) | Hyperaldosteronism, number of patients (%) | 6 (15.8) | Hyperandrogenism, number of patients (%) | 2 (5.3) | Nonfunctional, number of patients (%) | 23 (60.5) | Mean baseline HDL-c, mg/dL (±standard deviation) | 53.3 (±16.3) | Baseline lipid therapy, number of patients (%) | | Yes | 10 (26.3) | No | 28 (73.7) |
|
|
26 patients had information on BMI at baseline.
|